Overview

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
A single center, single dose, open-label, randomized, 3-period, 6-sequence, crossover study conducted in normal healthy subjects to evaluate the effect of a high- and low-fat meal on the pharmacokinetics (PK), bioavailability (BA), and safety of COV155.
Phase:
Phase 1
Details
Lead Sponsor:
Mallinckrodt